TY - JOUR
T1 - Association of walking with survival and RRT among patients with CKD stages 3–5
AU - Chen, I. Ru
AU - Wang, Su Ming
AU - Liang, Chih Chia
AU - Kuo, Huey Liang
AU - Chang, Chiz Tzung
AU - Liu, Jiung Hsiun
AU - Lin, Hsin Hung
AU - Wang, I. Kuan
AU - Yang, Ya Fei
AU - Chou, Che Yi
AU - Huang, Chiu Ching
N1 - Publisher Copyright:
© 2014 by the American Society of Nephrology.
PY - 2014
Y1 - 2014
N2 - Background and objectives Patientswith CKD can benefit froman increase in physical activity. Walking is one of themost common exercises in patients with CKD; however, the association of walkingwith outcomes in patients with CKD is not clear. This study investigated the association of walking with overall mortality and RRT in patients with CKD stages 3–5. Design, setting, participants, & measurements All patients with CKD stages 3–5 in the CKD program of China Medical University Hospital from June 2003 to May 2013 were enrolled. The risks of overall mortality and RRT were analyzed using competing-risks regressions. Results Atotal of 6363 patients (average age, 70 years) during a median of 1.3 (range=0.6–2.5) years of follow-up were analyzed. There were 1341 (21.1%) patients who reported walking as their most common form of exercise. The incidence density rate of overall mortality was 2.7 per 100 person-years for walking patients and 5.4 for nonwalking ones. The incidence density rate of RRT was 22 per 100 person-years for walking patients and 32.9 for nonwalking ones.Walking, independent of patients’ age, renal function, and comorbidity, was linked to lower overall mortality and lower RRT risk in the multivariate competing-risks regression. The adjusted subdistribution hazard ratio (SHR) of walking was 0.67 (95% confidence interval [95% CI], 0.53 to 0.84; P<0.001) for overall mortality and 0.79 (95% CI, 0.73 to 0.85; P<0.001) for the risk of RRT. The SHRs of overallmortality were 0.83, 0.72, 0.42, and 0.41 for patients walking 1–2, 3–4, 5–6, and ≥7 times per week, and the SHRs of RRT were 0.81, 0.73, 0.57, and 0.56, respectively. Conclusions Walking is the most popular form of exercise in patients with CKD and is associated with lower risks of overall mortality and RRT. The benefit of walking is independent of patients’ age, renal function, and comorbidity.
AB - Background and objectives Patientswith CKD can benefit froman increase in physical activity. Walking is one of themost common exercises in patients with CKD; however, the association of walkingwith outcomes in patients with CKD is not clear. This study investigated the association of walking with overall mortality and RRT in patients with CKD stages 3–5. Design, setting, participants, & measurements All patients with CKD stages 3–5 in the CKD program of China Medical University Hospital from June 2003 to May 2013 were enrolled. The risks of overall mortality and RRT were analyzed using competing-risks regressions. Results Atotal of 6363 patients (average age, 70 years) during a median of 1.3 (range=0.6–2.5) years of follow-up were analyzed. There were 1341 (21.1%) patients who reported walking as their most common form of exercise. The incidence density rate of overall mortality was 2.7 per 100 person-years for walking patients and 5.4 for nonwalking ones. The incidence density rate of RRT was 22 per 100 person-years for walking patients and 32.9 for nonwalking ones.Walking, independent of patients’ age, renal function, and comorbidity, was linked to lower overall mortality and lower RRT risk in the multivariate competing-risks regression. The adjusted subdistribution hazard ratio (SHR) of walking was 0.67 (95% confidence interval [95% CI], 0.53 to 0.84; P<0.001) for overall mortality and 0.79 (95% CI, 0.73 to 0.85; P<0.001) for the risk of RRT. The SHRs of overallmortality were 0.83, 0.72, 0.42, and 0.41 for patients walking 1–2, 3–4, 5–6, and ≥7 times per week, and the SHRs of RRT were 0.81, 0.73, 0.57, and 0.56, respectively. Conclusions Walking is the most popular form of exercise in patients with CKD and is associated with lower risks of overall mortality and RRT. The benefit of walking is independent of patients’ age, renal function, and comorbidity.
UR - http://www.scopus.com/inward/record.url?scp=84921529024&partnerID=8YFLogxK
U2 - 10.2215/CJN.09810913
DO - 10.2215/CJN.09810913
M3 - 文章
C2 - 24832096
AN - SCOPUS:84921529024
SN - 1555-9041
VL - 9
SP - 1183
EP - 1189
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 7
ER -